Breast Cancer Stem Cells

Breast cancer is marked mutually of the leading causes of malignancy-related morbidities worldwide. In spite of aggressive interventions, the inevitableness of relapse and metastasis severely impede survival rates. Mounting proof highlight the insidious role of cancer stem cells (CSCs), a little but important population of undifferentiated cells that drive growth progression, spread and resistance to standard therapy. The nature and significance of breast CSCs remains poorly understood, and even controversial by several researchers. This review discusses the origins, biomarkers, signalling pathways, restrictive mechanisms, and targeted therapy of breast CSCs

However, despite offered interventions, patients below remission should still develop carcinoma relapse and metastasis. Accumulating proof suggests that the underlying presence of a tiny low universe of undifferentiated cells, termed carcinoma stem cells (BCSCs), area unit presumably make to growth progression, spreading and resistance to traditional therapy.

 

    Related Conference of Breast Cancer Stem Cells

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Breast Cancer Stem Cells Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in